STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Quantum Computing Inc (Nasdaq: QUBT) announced an oversubscribed private placement of 26,867,276 shares priced at market to raise approximately $500 million gross. The company said the offering includes participation by several large existing shareholders and a first-time investment from a global alternative asset manager. The closing is expected on or about September 24, 2025, subject to customary conditions. The company intends to use net proceeds for commercialization, strategic acquisitions, sales and engineering hires, working capital, and general corporate purposes. The securities have not been registered under the Securities Act; the company agreed to file a resale registration statement. The company reported total gross capital raised since November 2024 of approximately $900 million and an expected post-close cash position of about $850 million.

Loading...
Loading translation...

Positive

  • Gross proceeds of $500 million from the private placement
  • 26,867,276 shares issued in an oversubscribed offering
  • Total gross capital raised of approximately $900 million since November 2024
  • Expected post-close $850 million total cash position

Negative

  • Securities not registered under the Securities Act, limiting immediate resale in the US

Market Reaction 15 min delay 15 Alerts

+9.69% Since News
$131.43 Last Price
$129.71 $136.50 Day Range
+$513M Valuation Impact
$5.81B Market Cap
0.4x Rel. Volume

Following this news, TFX has gained 9.69%, reflecting a notable positive market reaction. Our momentum scanner has triggered 15 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $131.43. This price movement has added approximately $513M to the company's valuation.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.

Key Figures

Shares in offering 26,867,276 shares Common stock sold in oversubscribed private placement
Gross proceeds $500 million Expected gross proceeds from private placement before expenses
Cash position $850 million Company total cash expected following closing
Capital raised since Nov 2024 $900 million Total gross capital raised since November 2024
Closing date September 24, 2025 Expected closing date of private placement, subject to conditions

Market Reality Check

$119.82 Last Close
Volume Volume 494,155 is below the 20-day average of 582,718 (relative volume 0.85x). normal
Technical Shares at $119.82 are trading below the 200-day MA of $125.21 and about 36.6% under the 52-week high.

Peers on Argus

Teleflex slipped 0.56% while key medical instrument peers like MMSI, BLCO, RGEN, STVN and NVST also traded lower (moves from -0.44% to -2.14%), suggesting a generally weak tape but without confirmed sector-wide momentum.

Historical Context

Date Event Sentiment Move Catalyst
Nov 14 Conference appearance Neutral -2.2% Jefferies London conference presentation and webcast details for investors.
Nov 06 Dividend declaration Positive -13.0% Announcement of a <b>$0.34</b> per share quarterly cash dividend.
Nov 06 Earnings and outlook Negative -13.0% Q3 results with large goodwill impairments and reduced EPS guidance.
Oct 16 Earnings call info Neutral +3.4% Scheduling details for Q3 2025 earnings call and VI investor meeting.
Sep 11 Clinical trial start Positive +1.7% First patient enrolled in DUBSTENT DIABETES PCI strategy trial in diabetics.
Pattern Detected

Recent Teleflex news often saw outsized downside on financial updates, with the Q3 2025 earnings and dividend announcements both followed by double‑digit percentage declines despite generally informational or mixed content.

Recent Company History

Over the last six months, Teleflex has combined clinical, strategic, and financial developments. Q3 2025 results showed GAAP revenue of $913.0M and significant non‑cash impairments totaling about $512.0M, alongside lowered EPS guidance, and the stock fell 13.02%. A quarterly dividend of $0.34 per share and conference appearances around earnings also coincided with weakness. Clinically, the DUBSTENT DIABETES trial began enrolling 120 patients, marking ongoing innovation in PCI strategies.

Market Pulse Summary

The stock is up +9.7% following this news. A strong positive reaction aligns with the sizable equity financing described, which adds an expected $500 million in gross proceeds and lifts the total cash position toward $850 million. Historically, Teleflex’s stock has reacted sharply to financial updates, especially those involving earnings and impairments. Investors would need to weigh balance sheet strengthening and growth funding against potential dilution from issuing 26,867,276 new shares and the risk that enthusiasm for capital raises can fade once the deal is fully absorbed.

Key Terms

securities purchase agreements financial
"announced that it has entered into securities purchase agreements with institutional"
A securities purchase agreement is a legal contract that spells out the terms when a company sells stocks, bonds, or other investment instruments to buyers. It lays out price, how many securities change hands, any promises or protections for each side, and when the sale is completed—like a detailed sales contract for investments. Investors care because it determines ownership stakes, potential dilution, rights attached to the securities, and conditions that affect the company’s future value.
private placement financial
"shares of common stock in an oversubscribed private placement priced at the market"
A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.
alternative asset manager financial
"first-time investment from a preeminent global alternative asset manager"
An alternative asset manager is a professional or firm that invests on behalf of clients in assets outside of traditional options like stocks and bonds, such as real estate, private companies, or commodities. These managers seek to diversify investment portfolios and potentially improve returns by exploring less common investment opportunities that are often less liquid and more specialized. Their work matters to investors because it can help spread risk and access unique sources of growth not available through standard investments.
resale registration statement regulatory
"The Company has agreed to file a resale registration statement with the SEC"
A resale registration statement is a document filed with regulators that allows existing shareholders to sell their shares to the public. It provides the necessary legal approval and information for these shares to be resold on the market, helping to increase the availability of shares for trading. For investors, it signals that shares held by current owners can be offered for sale, potentially affecting share prices and market liquidity.

AI-generated analysis. Not financial advice.

  • The offering is being led by several large existing shareholders alongside a first-time investment from a preeminent global alternative asset manager

  • Company's total cash position expected to be approximately $850 million following closing

HOBOKEN, N.J., Sept. 21, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, today announced that it has entered into securities purchase agreements with institutional investors for the purchase and sale of 26,867,276 shares of common stock in an oversubscribed private placement priced at the market under Nasdaq rules. The offering is expected to result in gross proceeds of $500 million, before deducting offering expenses. The closing of the offering is expected to occur on or about September 24, 2025, subject to the satisfaction of customary closing conditions.

Participants in the private placement include several large existing shareholders alongside a first-time investment from a preeminent global alternative asset manager.

The Company intends to use the net proceeds from the offering to accelerate commercialization efforts, strategic acquisitions, expand sales and engineering personnel, working capital, and general corporate purposes.

Titan Partners Group, a division of American Capital Partners, is acting as the sole placement agent for the offering.

"This successful $500 million offering, led by strong support from both new and existing leading institutional investors, is priced at a substantial premium to our four recent offerings, bringing our total gross capital raised since November 2024 to approximately $900 million," said Dr. Yuping Huang, CEO and Chairman of the Board of QCi. "This financing further fortifies our financial position and enables us to execute our multi-year growth plan, including the acceleration of commercialization efforts, strategic acquisitions, the expansion of sales and engineering personnel, and the strengthening of our manufacturing capabilities."

The securities issued in the private placement described above have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. The Company has agreed to file a resale registration statement with the SEC for purposes of registering the resale of the shares of common stock issued in connection with the private placement.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Quantum Computing Inc.

Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT) is an innovative, integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines and foundry services for the production of photonic chips based on thin-film lithium niobate (TFLN). QCi's products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer unique capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.

Forward-Looking Statements

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, generally identified by terms such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," "aim to," or variations of these or similar words, involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding and including statements regarding the expected closing of the offering, QCi's use of the net proceeds from the offering and the anticipated benefits that the Company may realize from the offering. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including the timing of orders and revenue, and the outcome of ongoing collaborations and demonstration projects with certain U.S. government agencies, academic institutions and commercial customers, and that actual results may differ materially from those contemplated by such forward-looking statements. Except as required by federal securities law, QCi undertakes no obligation to update or revise forward-looking statements to reflect changed conditions.

Company Contact:

Rosalyn Christian/John Nesbett

IMS Investor Relations

qci@imsinvestorrelations.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quantum-computing-inc-announces-500-million-oversubscribed-private-placement-of-common-stock-priced-at-the-market-under-nasdaq-rules-302562474.html

SOURCE Quantum Computing Inc.

FAQ

How many shares did Quantum Computing Inc (QUBT) sell in the September 2025 private placement?

Quantum Computing sold 26,867,276 shares in the private placement.

How much gross capital did QUBT raise in the September 2025 private placement?

The offering is expected to generate approximately $500 million in gross proceeds.

When is the QUBT private placement expected to close?

The closing is expected on or about September 24, 2025, subject to customary closing conditions.

What will QUBT use the net proceeds from the $500 million offering for?

Net proceeds are intended for commercialization, strategic acquisitions, sales and engineering hires, working capital, and general corporate purposes.

What will QUBT's cash position be after the closing of the private placement?

The company expects a total cash position of approximately $850 million following closing.

Are the shares from QUBT's private placement immediately tradable in the US?

No; the securities were not registered under the Securities Act and the company agreed to file a resale registration statement to register the resale of the shares.

Who participated in QUBT's September 2025 private placement?

Participants include several large existing shareholders and a first-time investment from a preeminent global alternative asset manager.
Teleflex Inc

NYSE:TFX

TFX Rankings

TFX Latest News

TFX Latest SEC Filings

TFX Stock Data

5.33B
44.04M
0.33%
102.8%
2.13%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
WAYNE